Synergistic cell death induction in breast cancer cell lines by combining ABT-199 and cisplatin irrespective of estrogen receptor and p53 expression.

被引：0
|
作者：
Schaefer, Benjamin [1 ,2 ]
Weller, Sandra [1 ,2 ]
Beigl, Tobias [1 ,2 ]
Boepple, Kathrin [1 ,2 ]
Hoppe, Reiner [1 ,2 ]
Schulze-Osthoff, Klaus [2 ]
Kopp, Hans-Georg [3 ,4 ]
Aulitzky, Walter E. [3 ]
Essmann, Frank [1 ,2 ]
机构：
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[2] Univ Tubingen, Stuttgart, Germany
[3] Robert Bosch Krankenhaus, Stuttgart, Germany
[4] Robert Bosch Ctr Tumor Dis, Stuttgart, Germany
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1946
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines
    Tong, D
    Schuster, E
    Seifert, M
    Czerwenka, K
    Leodolter, S
    Zeillinger, R
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 71 (03) : 249 - 255
  • [32] Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines
    Dan Tong
    Eva Schuster
    Michael Seifert
    Klaus Czerwenka
    Sepp Leodolter
    Robert Zeillinger
    Breast Cancer Research and Treatment, 2002, 71 : 249 - 255
  • [33] Expression of Fas-estrogen receptor fusion protein induces cell death in pancreatic cancer cell lines
    Kawaguchi, Y
    Takebayashi, H
    Kakizuka, A
    Arii, S
    Kato, M
    Imamura, M
    CANCER LETTERS, 1997, 116 (01) : 53 - 59
  • [34] Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin
    Pagliaro, LC
    Keyhani, A
    Liu, BS
    Perrotte, P
    Wilson, D
    Dinney, CP
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (06) : 456 - 462
  • [35] The role of functional p53 in cisplatin chemosensitivity in a panel of human ovarian cancer cell lines.
    Walton, MI
    Koshy, P
    Medlow, CJ
    Sharp, S
    Kelland, LR
    Sharp, S
    Titley, J
    BRITISH JOURNAL OF CANCER, 1998, 78 : 19 - 19
  • [36] Expression of bcl-2 and p53 in Induction of Esophageal Cancer Cell Apoptosis by ECRG2 in Combination with Cisplatin
    Song, Hai-Yan
    Deng, Xiao-Hui
    Yuan, Guo-Yan
    Hou, Xin-Fang
    Zhu, Zhen-Dong
    Zhou, Li
    Ren, Ming-Xin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (03) : 1397 - 1401
  • [37] Effects of triptolide from Tripterygium wilfordii on ERα and p53 expression in two human breast cancer cell lines
    Liu, Jing
    Jiang, Zhenzhou
    Xiao, Jingwei
    Zhang, Yun
    Lin, Sensen
    Duan, Weigang
    Yao, Jincheng
    Liu, Chunhui
    Huang, Xin
    Wang, Tao
    Liang, Zhongliang
    Wang, Rongrong
    Zhang, Shuang
    Zhang, Luyong
    PHYTOMEDICINE, 2009, 16 (11) : 1006 - 1013
  • [38] The influence of p53 mutation status on the anti-cancer effect of cisplatin in oral squamous cell carcinoma cell lines
    Jo, Deuk-Won
    Kim, Young-Kyun
    Yun, Pil-Young
    JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2016, 42 (06) : 337 - 344
  • [39] Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation
    Konduri, Santhi D.
    Medisetty, Rajesh
    Liu, Wensheng
    Kaipparettu, Benny Abraham
    Srivastava, Pratima
    Brauch, Hiltrud
    Fritz, Peter
    Swetzig, Wendy M.
    Gardner, Amanda E.
    Khan, Sohaib A.
    Das, Gokul M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (34) : 15081 - 15086
  • [40] Inhibition of breast cancer tumor cell lines by simvastatin is dependent on specific p53 mutation
    Ferdosi, S. R.
    Grewal, H.
    Gonzalez-Malerva, L.
    Eaton, S.
    Briones, N.
    LaBaer, J.
    Anderson, K. S.
    CANCER RESEARCH, 2016, 76
12345